Laxxon Medical Ltd offers interested companies in the pharmaceutical industry the chance to evaluate the 3D screen-printing process for the future production of their products by means of a jointly defined project.
As part of the project collaboration the traditional approach is to jointly develop and implement expectations (scope, objectives), staffing, methodology, requirements (process steps), scheduling, costs and risks.
Laxxon Medical Ltd has the required process expertise and therefore access to a 3D screen-printing test facility, with which the appropriate products can be developed and manufactured as part of the project.
Are you interested in cooperating with Laxxon Medical Ltd and would you like to take part in a project to evaluate the application options of 3D screen-printing technology for your company? We would be happy to have a non-binding discussion with you and look forward to hearing from you.